Latest Nasdaq Listing News

Jindalee Lithium Limited's US subsidiary, HiTech Minerals, has signed a binding agreement with Constellation Acquisition Corp I to form US Elemental Inc., a NASDAQ-listed company holding the McDermitt Lithium Project. The transaction values the new entity at approximately US$571 million enterprise value, with Jindalee retaining majority ownership.

Resolution Minerals Ltd has secured FAST-41 status for its Antimony Ridge project in Idaho, a designation expected to accelerate permitting and development of this critical minerals asset. The move supports the company's integrated U.S. strategy for antimony, tungsten, and gold, enhancing investor visibility and strategic engagement.

Nova Minerals has amended its warrant exchange terms, tripling the ratio for Nasdaq-listed warrants to US Holdco warrants as part of its US redomiciliation plan. This adjustment aligns with NYSE listing requirements and signals a strategic step in the company’s transition.

CLINUVEL Pharmaceuticals reports record first-half profits and confirms CEO Philippe Wolgen’s leadership through a pivotal growth phase, prioritising its vitiligo program and Nasdaq ambitions.

Alliance Nickel is advancing its NiWest project by exploring vat leaching to reduce capital costs and has completed initial gold drilling at Wanbanna, while continuing offtake talks with Stellantis and considering a NASDAQ listing via de-SPAC.

Ovanti Limited has terminated its SPAC transaction with Miluna Acquisition Corp, shifting focus to alternative NASDAQ listing opportunities better aligned with its U.S. expansion strategy. The company is strengthening leadership and accelerating its U.S. growth plans.

Ovanti Limited announces a strategic leadership change in its US operations to boost its BNPL platform Flote’s commercialisation and prepare for a potential NASDAQ listing via SPAC.

Aurora Energy Metals has completed the sale of its Aurora Uranium Project to Eagle Nuclear Energy, receiving A$24.2 million in equity and retaining future milestone-linked payments and royalties.

Island Pharmaceuticals reports a 213.8% increase in half-year loss to $4.81 million, driven by strategic acquisition and clinical development investments. The company advances its antiviral portfolio with Galidesivir and ISLA-101, supported by strong US regulatory engagement and a $9 million capital raise.

American Tungsten & Antimony Ltd (ASX, AT4) has produced its first antimony ingots from its Utah project, validating its processing approach and advancing its US growth ambitions including a planned Nasdaq listing.

Nova Minerals plans to redomicile to the United States following the loss of its foreign private issuer status, while acquiring full ownership of its Estelle Gold and Critical Minerals Project and appointing a US-based CFO.

The Federal Court of Australia has approved the acquisition schemes for Global Uranium and Enrichment Limited by Snow Lake Resources, setting the stage for a significant shift in shareholder structure and market listing.